KMTS financial statements
The full income statement, balance sheet, and cash-flow statement for Kestra Medical Technologies Ltd. (KMTS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| Income Statement | as ofApr 30 ’26 | as ofApr 30 ’25 | as ofApr 30 ’24 | |
| Revenue | 95.1M+59.0% | 59.8M+115.1% | 27.8M | |
| 48.9M+101.8% | 24.2M+6587.8% | 362K | ||
| Cost of revenue | 46.3M+29.9% | 35.6M+29.7% | 27.5M | |
| 184M+40.6% | 131M+52.9% | 85.4M | ||
| Research & development | 19.5M+24.5% | 15.7M+1.0% | 15.5M | |
| Selling, general & administrative | 164M+42.8% | 115M+64.3% | 69.9M | |
| Operating income | -135M-26.7% | -106M-25.1% | -85.1M | |
| Interest expense | 7.55M-2.4% | 7.73M+24.1% | 6.23M | |
| Interest & investment income | 8.35M+161.1% | 3.20M | — | |
| Other non-operating income | 2.62M+194.6% | -2.77M+1.3% | -2.80M | |
| Gain (loss) on equity securities | -218K | — | — | |
| Pre-tax income | -131M-15.5% | -114M-20.8% | -94.1M | |
| Income tax | 294K+117.8% | 135K+462.5% | 24.0K | |
| -132M-15.6% | -114M-20.9% | -94.1M | ||
| Net income to common | -132M-4.3% | -126M-25.1% | -101M | |
| -$2.43+52.6% | -$5.13-1.2% | -$5.07 | ||
| EPS (basic) | -$2.43+52.6% | -$5.13-1.2% | -$5.07 | |
| Weighted-avg shares (basic) | 54.2M+120.4% | 24.6M+23.6% | 19.9M | |
| Weighted-avg shares (diluted) | 54.2M+120.4% | 24.6M+23.6% | 19.9M | |
| Balance Sheet | as ofApr 30 ’26 | as ofApr 30 ’25 | as ofApr 30 ’24 | |
| 222M-12.9% | 255M+1612.8% | 14.9M | ||
| Cash & equivalents | 99.7M-58.0% | 238M+2780.3% | 8.25M | |
| Short-term investments | 96.7M | — | — | |
| Cash & short-term investments | 262M | — | — | |
| Accounts receivable | 14.5M+80.0% | 8.08M+304.5% | 2.00M | |
| Prepaid expenses | 4.68M+51.9% | 3.08M+124.8% | 1.37M | |
| Other current assets | 2.98M+76.3% | 1.69M+304.1% | 419K | |
| 358M+21.2% | 296M+543.6% | 45.9M | ||
| Property, plant & equipment | 59.1M+69.7% | 34.8M+33.4% | 26.1M | |
| Operating lease right-of-use | 3.36M+61.9% | 2.08M-9.1% | 2.29M | |
| Long-term investments | 65.8M | — | — | |
| Other non-current assets | 5.79M+402.2% | 1.15M+90.0% | 607K | |
| 50.4M+32.6% | 38.0M+15.2% | 33.0M | ||
| Accounts payable | 27.3M+13.9% | 24.0M+0.3% | 23.9M | |
| Accrued liabilities | 23.0M+66.6% | 13.8M+52.3% | 9.08M | |
| Current lease liability | 31.0K-83.4% | 187K | — | |
| 98.8M+9.4% | 90.3M+15.5% | 78.2M | ||
| Long-term debt | 42.6M+3.8% | 41.1M-3.4% | 42.5M | |
| Non-current lease liability | 4.11M+35.9% | 3.03M+14.9% | 2.63M | |
| Operating lease liability (total) | 4.14M+28.9% | 3.21M | — | |
| Other non-current liabilities | 306K+118.6% | 140K+84.2% | 76.0K | |
| 260M+26.4% | 205M+198.1% | -209M | ||
| Common stock | 58.4M+13.7% | 51.3M+157.9% | 19.9M | |
| Additional paid-in capital | 853M+26.6% | 674M+280.6% | 177M | |
| Retained earnings | -652M-25.3% | -520M-28.0% | -406M | |
| Accumulated other comprehensive income | -218K | — | — | |
| Total equity incl. non-controlling | 260M+26.4% | 205M+198.1% | -209M | |
| Total liabilities & equity | 358M+21.2% | 296M+543.6% | 45.9M | |
| Common shares issued | 58.4M+13.7% | 51.3M-51.5% | 106M | |
| Common shares outstanding | 58.4M+13.7% | 51.3M-51.5% | 106M | |
| Shares outstanding (cover) | 58.6M+14.1% | 51.3M | — | |
| Cash Flow | as ofApr 30 ’26 | as ofApr 30 ’25 | as ofApr 30 ’24 | |
| -81.7M-5.3% | -77.6M-7.4% | -72.2M | ||
| Depreciation & amortization | 8.71M+9.3% | 7.97M-31.1% | 11.6M | |
| Share-based compensation | 33.6M+38.6% | 24.3M+1531.0% | 1.49M | |
| Deferred income taxes | 166K+159.4% | 64.0K+433.3% | 12.0K | |
| Change in receivables | 9.06M+3.2% | 8.78M+251.4% | 2.50M | |
| Change in payables | 4.30M+51.4% | 2.84M-61.3% | 7.34M | |
| -203M-772.1% | -23.3M-90.6% | -12.2M | ||
| Capital expenditure | 34.9M+52.1% | 22.9M+87.6% | 12.2M | |
| Free cash flow | -117M-16.0% | -101M-19.0% | -84.5M | |
| Acquisitions | 0.00 | 0.00 | 0.00 | |
| 147M-55.5% | 330M+324.9% | 77.7M | ||
| Long-term debt issued | 0.00 | 0.00-100.0% | 45.0M | |
| Long-term debt repaid | 0.00 | 0.00-100.0% | 39.1M | |
| Common stock issued | 149M-30.8% | 216M | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -138M-160.1% | 229M+3503.3% | -6.74M | |
| Interest paid | 5.64M+16.4% | 4.85M+33.6% | 3.63M | |
| Income taxes paid | 13.0K-84.3% | 83.0K+376.7% | -30.0K | |
| Valuation Ratios | as ofApr 30 ’26 | as ofApr 30 ’25 | as ofApr 30 ’24 | |
| Market cap | 1.21B-1.7% | 1.24B | — | |
| P/S | 12.8×-38.2% | 20.7× | — | |
| P/B | 4.7×-22.3% | 6.0× | — | |
| Source filing | 10-K | 10-K | 10-K |
About this data
Source: KMTS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all KMTS filings on SEC EDGAR → Not investment advice.